Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenstr öm Macroglobulinemia

Conditions:   Waldenstrom's Disease;   Waldenstrom Macroglobulinemia Interventions:   Biological: bone marrow sample;   Biological: blood sample Sponsors:   Centre Hospitalier Universitaire, Amiens;   Centre Henri Becquerel;   University Hospital, Caen;   University Hospital, Lille;   Centre Hospitalier de Lens Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials